A mechanism-based classification of pain in multiple sclerosis
Abstract Pharmacological treatment of pain in multiple sclerosis (MS) is challenging due to the many underlying pathophysiological mechanisms. Few controlled…
central spasticity
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
Abstract Cannabinoids such as Cannabis-based medicinal extracts (CBMEs) are increasingly being used in the treatment of spasticity associated with multiple…
Cannabinoids in the management of spasticity associated with multiple sclerosis
Abstract The endocannabinoid system and cannabinoid-based treatments have been involved in a wide number of diseases. In particular, several studies…